Article: Appointments And Advancements.

Celldex Therapeutics, of Phillipsburg, N.J., appointed Ronald Newbold vice president of business development, and Robert Forbes Burns CEO.

Cephalon Inc., of Frazer, Pa., appointed Kevin Moley to its board.

ChondroGene Ltd., of Toronto, appointed David Tyler director, product development and quality assurance.

ConjuChem Inc., of Montreal, appointed Thomas Ulich executive vice president, research and development.

Esbatech AG, of Zurich, Switzerland, appointed James Egan chief business officer.

Foley & Lardner LLP, of Boston, appointed Sven Riethmueller a member of its business law department and life sciences and emerging ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!